CVI Holdings’s Erasca ERAS Stock Holding History

CVI Holdings’s Portfolio ERAS Stock Details ERAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,456,311	Closed	-$3M	–	150
2024 Q1	$3M	Buy	+1,456,311	New	+$2.91M	2.82%	5
2023 Q1	–	Sell	-376,716	Closed	-$1.62M	–	426
2022 Q4	$1.62M	Buy	+376,716	New	+$2.55M	0.21%	151

Other funds holding ERAS

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

CVI Holdings's ERAS Position: Q2 2024 in Review

CVI Holdings sold out of Erasca (ERAS) in Q2 2024, closing a stake of 1,456,311 shares — an estimated $3M sold.

CVI Holdings first reported a position in ERAS in Q4 2022 and held it in 2 quarters. The position peaked at $3M in Q1 2024. 125 funds tracked by Wall St. Rank hold ERAS as of Q2 2024.

CVI Holdings reported no remaining Erasca position as of Q2 2024 after selling out during the quarter.
CVI Holdings sold 1,456,311 Erasca shares in Q2 2024, an estimated $3M.
CVI Holdings first reported a position in Erasca in Q4 2022 and held it in 2 quarters.
CVI Holdings's Erasca position peaked at $3M in Q1 2024.
125 funds tracked by Wall St. Rank held Erasca as of Q2 2024.

Based on CVI Holdings's 13F filing for Q2 2024, filed 15 Aug 2024.